Economics at your fingertips  

The Effect of Regulated Competition on Pharmaceutical Advertising and Promotion

Guy David () and Sara Markowitz ()
Additional contact information
Guy David: University of Pennsylvania and NBER, 202 Colonial Penn Center, 3641 Locust Walk, Philadelphia, PA 19104, USA.

Eastern Economic Journal, 2015, vol. 41, issue 1, 24-39

Abstract: Pharmaceutical advertising and promotion are distinct in that the firm’s decisions are highly interconnected with issues surrounding consumer safety. Expenditure decisions must balance profitable demand expansions with potential regulatory actions, and depend on the nature of competition (monopoly versus oligopoly). We develop a model of the firm’s choice of expenditures under different competitive scenarios with consideration of possible regulatory action. We test the model’s predictions with data from the market for erectile dysfunction drugs, which is ideal for analysis as it experienced an abrupt shift in structure and faced regulatory action. We find that advertising and promotion expenditures increase sales but the magnitudes are sensitive to competition and regulation.

Date: 2015
References: Add references at CitEc
Citations: Track citations by RSS feed

Downloads: (external link) Link to full text PDF (application/pdf) Link to full text HTML (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Ordering information: This journal article can be ordered from

Access Statistics for this article

Eastern Economic Journal is currently edited by Allan Zebedee and Cynthia Bansak

More articles in Eastern Economic Journal from Palgrave Macmillan, Eastern Economic Association Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla ().

Page updated 2019-12-23
Handle: RePEc:pal:easeco:v:41:y:2015:i:1:p:24-39